Solubility: Soluble in DMSO (80 mg/ml), or ethanol (25 mg/ml)
Appearance: White powder
PubChem CID: 11556711
Scientific Background: Carfilzomib / PR-17 is an irreversible proteasome inhibitor that targets the chymotrypsin-like beta5 subunit of 20S proteasome. It can arrest the cell cycle and trigger apoptosis in tumor cell lines.
Field of Use: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.